Abstract
Imidazoline binding sites (IBS) were proposed to be responsible for some of the pharmacological and therapeutic activities of imidazoline and related compounds and have been classified into two subtypes, I1BS and I2BS. Convergent studies attribute a role in central blood pressure regulation to the I1BS. In contrast, the function of I2BS remains unknown. In the present study, by combining biochemical and molecular biology approaches, we show that 1) microsequencing of I2BS purified from rabbit kidney mitochondria allowed the recovery of four peptide sequence stretches displaying up to 85.7% similarity with human, rat, and bovine monoamine oxidases (MAO)-A and -B; 2) I2BS and MAO displayed identical biophysical characteristics as their activities, measured by [3H]idazoxan binding and [14C]tyramine oxidation, respectively, could not be separated using various chromatographic procedures; and 3) heterologous expression of human placenta MAO-A and human liver MAO-B in yeast, inherently devoid of I2BS and MAO activities, led to the coexpression of [3H]idazoxan binding sites displaying ligand-recognition properties typical of I2BS. These results show definitely that I2BS is located on both MAO-A and -B. The fact that I2BS ligands inhibited MAO activity independently of the interaction with the catalytic region suggests that I2BS might be a previously unknown MAO regulatory site.
Highlights
Imidazoline binding sites were proposed to be responsible for some of the pharmacological and therapeutic activities of imidazoline and related compounds and have been classified into two subtypes, I1BS and 12BS
Convergent studies attribute a role in central blood pressure regulation to the IIBS
By combining biochemical and molecular biology approaches, we show that 1) microsequencing of 12BS purified from rabbit kidney mitochondria allowed the recovery of four peptide sequence stretches displaying up to 85.7% similarity with human, rat, and bovine monoamine oxidases (MAO)-A and -B; 2) 12BS and MAO displayed identical biophysical characteristics as their activities, measured by [3Hlidazoxan binding and rt4Cltyra m in e oxidation, respectively, could not be separated using various chromatographic procedures; and 3) heterologous expression of human placenta MAO·A and human liver MAO-B in yeast, inherently devoid of 12BS and MAO activities, led to the coexpression of [3Hlidazoxan binding sites displaying ligand-recognition properties typical of I2BS
Summary
(Received for publication, December 29, 1994, and in revised form, February 20, 1995). By comparing the structural and regulatory properties of IzBS with those of other outer membrane mitochondrial proteins, we observed that IzBS share with monoamine oxidases (MAO), enzymes metabolizing endogenous active substances (i.e. adrenaline, noradrenaline, serotonin, and dopamine) and exogenous amines, the same molecular weight, subcellular localization, and ion regulation. This prompted us to investigate the structural and functional relationships between IzBS and MAO. The fact that IzBS ligands inhibited MAO activity independently of the interaction with the catalytic region suggests that IzBS might be involved in the regulation of the enzyme activity
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
